Efficacy of palbociclib plus fulvestrant in advanced Hormone Receptor-positive (HR+) metastatic breast cancer (MBC) pretreated with everolimus: Real-life data from the french temporary authorization for use (TAU) at the Institut de Cancérologie de l’Ouest Article Swipe

PDF

Pauline du Rusquec , Clément Palpacuer , L. Campion , Anne Patsouris , Paule Augereau , Carole Gourmelon , M. Robert , L.E. Dumas , C. Folliard , Mario Campone , Jean‐Sébastien Frenel ·

YOU? · · 2017 · Open Access · · DOI: https://doi.org/10.1093/annonc/mdx365.019

Related Topics

Concepts

Palbociclib Fulvestrant Medicine Metastatic breast cancer Everolimus Internal medicine Oncology Population Cancer Breast cancer Progression-free survival Chemotherapy Tamoxifen Environmental health

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1093/annonc/mdx365.019
PDF: https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.019/19938751/mdx365.019.pdf
OA Status: bronze
Related Works: 10
OpenAlex ID: https://openalex.org/W2763200037

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W2763200037

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1093/annonc/mdx365.019

Digital Object Identifier
Title: Efficacy of palbociclib plus fulvestrant in advanced Hormone Receptor-positive (HR+) metastatic breast cancer (MBC) pretreated with everolimus: Real-life data from the french temporary authorization for use (TAU) at the Institut de Cancérologie de l’Ouest

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2017

Year of publication
Publication date: 2017-09-01

Full publication date if available
Authors: Pauline du Rusquec, Clément Palpacuer, L. Campion, Anne Patsouris, Paule Augereau, Carole Gourmelon, M. Robert, L.E. Dumas, C. Folliard, Mario Campone, Jean‐Sébastien Frenel

List of authors in order
Landing page: https://doi.org/10.1093/annonc/mdx365.019

Publisher landing page
PDF URL: https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.019/19938751/mdx365.019.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.019/19938751/mdx365.019.pdf

Direct OA link when available
Concepts: Palbociclib, Fulvestrant, Medicine, Metastatic breast cancer, Everolimus, Internal medicine, Oncology, Population, Cancer, Breast cancer, Progression-free survival, Chemotherapy, Tamoxifen, Environmental health

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W2763200037
doi	https://doi.org/10.1093/annonc/mdx365.019
ids.doi	https://doi.org/10.1093/annonc/mdx365.019
ids.mag	2763200037
ids.openalex	https://openalex.org/W2763200037
fwci	0.0
type	article
title	Efficacy of palbociclib plus fulvestrant in advanced Hormone Receptor-positive (HR+) metastatic breast cancer (MBC) pretreated with everolimus: Real-life data from the french temporary authorization for use (TAU) at the Institut de Cancérologie de l’Ouest
biblio.issue
biblio.volume	28
biblio.last_page	v82
biblio.first_page	v82
topics[0].id	https://openalex.org/T12829
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9995999932289124
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Advanced Breast Cancer Therapies
topics[1].id	https://openalex.org/T10755
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9944999814033508
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	HER2/EGFR in Cancer Research
topics[2].id	https://openalex.org/T10754
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9890000224113464
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2713
topics[2].subfield.display_name	Epidemiology
topics[2].display_name	Neuroendocrine Tumor Research Advances
is_xpac	False
apc_list.value	4060
apc_list.currency	USD
apc_list.value_usd	4060
apc_paid
concepts[0].id	https://openalex.org/C2779744173
concepts[0].level	5
concepts[0].score	0.9619665741920471
concepts[0].wikidata	https://www.wikidata.org/wiki/Q15269707
concepts[0].display_name	Palbociclib
concepts[1].id	https://openalex.org/C2780482068
concepts[1].level	5
concepts[1].score	0.9435200095176697
concepts[1].wikidata	https://www.wikidata.org/wiki/Q5508491
concepts[1].display_name	Fulvestrant
concepts[2].id	https://openalex.org/C71924100
concepts[2].level	0
concepts[2].score	0.9317225217819214
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[2].display_name	Medicine
concepts[3].id	https://openalex.org/C2775930923
concepts[3].level	4
concepts[3].score	0.7676078677177429
concepts[3].wikidata	https://www.wikidata.org/wiki/Q12859063
concepts[3].display_name	Metastatic breast cancer
concepts[4].id	https://openalex.org/C2779699572
concepts[4].level	2
concepts[4].score	0.6853440999984741
concepts[4].wikidata	https://www.wikidata.org/wiki/Q421052
concepts[4].display_name	Everolimus
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.6119450926780701
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
concepts[6].id	https://openalex.org/C143998085
concepts[6].level	1
concepts[6].score	0.5902571082115173
concepts[6].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[6].display_name	Oncology
concepts[7].id	https://openalex.org/C2908647359
concepts[7].level	2
concepts[7].score	0.47228389978408813
concepts[7].wikidata	https://www.wikidata.org/wiki/Q2625603
concepts[7].display_name	Population
concepts[8].id	https://openalex.org/C121608353
concepts[8].level	2
concepts[8].score	0.47186797857284546
concepts[8].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[8].display_name	Cancer
concepts[9].id	https://openalex.org/C530470458
concepts[9].level	3
concepts[9].score	0.455527126789093
concepts[9].wikidata	https://www.wikidata.org/wiki/Q128581
concepts[9].display_name	Breast cancer
concepts[10].id	https://openalex.org/C2780739268
concepts[10].level	3
concepts[10].score	0.4129164218902588
concepts[10].wikidata	https://www.wikidata.org/wiki/Q2112244
concepts[10].display_name	Progression-free survival
concepts[11].id	https://openalex.org/C2776694085
concepts[11].level	2
concepts[11].score	0.3551860451698303
concepts[11].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[11].display_name	Chemotherapy
concepts[12].id	https://openalex.org/C2777176818
concepts[12].level	4
concepts[12].score	0.14461690187454224
concepts[12].wikidata	https://www.wikidata.org/wiki/Q412178
concepts[12].display_name	Tamoxifen
concepts[13].id	https://openalex.org/C99454951
concepts[13].level	1
concepts[13].score	0.0
concepts[13].wikidata	https://www.wikidata.org/wiki/Q932068
concepts[13].display_name	Environmental health
keywords[0].id	https://openalex.org/keywords/palbociclib
keywords[0].score	0.9619665741920471
keywords[0].display_name	Palbociclib
keywords[1].id	https://openalex.org/keywords/fulvestrant
keywords[1].score	0.9435200095176697
keywords[1].display_name	Fulvestrant
keywords[2].id	https://openalex.org/keywords/medicine
keywords[2].score	0.9317225217819214
keywords[2].display_name	Medicine
keywords[3].id	https://openalex.org/keywords/metastatic-breast-cancer
keywords[3].score	0.7676078677177429
keywords[3].display_name	Metastatic breast cancer
keywords[4].id	https://openalex.org/keywords/everolimus
keywords[4].score	0.6853440999984741
keywords[4].display_name	Everolimus
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.6119450926780701
keywords[5].display_name	Internal medicine
keywords[6].id	https://openalex.org/keywords/oncology
keywords[6].score	0.5902571082115173
keywords[6].display_name	Oncology
keywords[7].id	https://openalex.org/keywords/population
keywords[7].score	0.47228389978408813
keywords[7].display_name	Population
keywords[8].id	https://openalex.org/keywords/cancer
keywords[8].score	0.47186797857284546
keywords[8].display_name	Cancer
keywords[9].id	https://openalex.org/keywords/breast-cancer
keywords[9].score	0.455527126789093
keywords[9].display_name	Breast cancer
keywords[10].id	https://openalex.org/keywords/progression-free-survival
keywords[10].score	0.4129164218902588
keywords[10].display_name	Progression-free survival
keywords[11].id	https://openalex.org/keywords/chemotherapy
keywords[11].score	0.3551860451698303
keywords[11].display_name	Chemotherapy
keywords[12].id	https://openalex.org/keywords/tamoxifen
keywords[12].score	0.14461690187454224
keywords[12].display_name	Tamoxifen
language	en
locations[0].id	doi:10.1093/annonc/mdx365.019
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S41454044
locations[0].source.issn	0923-7534, 1569-8041
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0923-7534
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of Oncology
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].license	publisher-specific-oa
locations[0].pdf_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.019/19938751/mdx365.019.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/publisher-specific-oa
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of Oncology
locations[0].landing_page_url	https://doi.org/10.1093/annonc/mdx365.019
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5029402729
authorships[0].author.orcid	https://orcid.org/0000-0001-5803-4850
authorships[0].author.display_name	Pauline du Rusquec
authorships[0].countries	FR
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[0].affiliations[0].raw_affiliation_string	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[0].institutions[0].id	https://openalex.org/I4210147289
authorships[0].institutions[0].ror	https://ror.org/05jm9mh74
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I4210147289
authorships[0].institutions[0].country_code	FR
authorships[0].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[0].author_position	first
authorships[0].raw_author_name	P. Du Rusquec
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[1].author.id	https://openalex.org/A5079801798
authorships[1].author.orcid	https://orcid.org/0000-0001-5440-1860
authorships[1].author.display_name	Clément Palpacuer
authorships[1].countries	FR
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[1].affiliations[0].raw_affiliation_string	Biostatistics, Centre Rene Gauducheau, Nantes, France
authorships[1].institutions[0].id	https://openalex.org/I4210147289
authorships[1].institutions[0].ror	https://ror.org/05jm9mh74
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I4210147289
authorships[1].institutions[0].country_code	FR
authorships[1].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[1].author_position	middle
authorships[1].raw_author_name	C. Palpacuer
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Biostatistics, Centre Rene Gauducheau, Nantes, France
authorships[2].author.id	https://openalex.org/A5001022411
authorships[2].author.orcid	https://orcid.org/0000-0003-4903-0908
authorships[2].author.display_name	L. Campion
authorships[2].countries	FR
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[2].affiliations[0].raw_affiliation_string	Biostatistics, Centre Rene Gauducheau, Nantes, France
authorships[2].institutions[0].id	https://openalex.org/I4210147289
authorships[2].institutions[0].ror	https://ror.org/05jm9mh74
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I4210147289
authorships[2].institutions[0].country_code	FR
authorships[2].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[2].author_position	middle
authorships[2].raw_author_name	L. Campion
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Biostatistics, Centre Rene Gauducheau, Nantes, France
authorships[3].author.id	https://openalex.org/A5062193270
authorships[3].author.orcid	https://orcid.org/0000-0001-9101-5424
authorships[3].author.display_name	Anne Patsouris
authorships[3].affiliations[0].raw_affiliation_string	Medical Oncology, Centre Paul Papin, Angers, France
authorships[3].author_position	middle
authorships[3].raw_author_name	A. Patsouris
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Medical Oncology, Centre Paul Papin, Angers, France
authorships[4].author.id	https://openalex.org/A5026699354
authorships[4].author.orcid	https://orcid.org/0000-0002-4748-0799
authorships[4].author.display_name	Paule Augereau
authorships[4].affiliations[0].raw_affiliation_string	Medical Oncology, Centre Paul Papin, Angers, France
authorships[4].author_position	middle
authorships[4].raw_author_name	P. Augereau
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Medical Oncology, Centre Paul Papin, Angers, France
authorships[5].author.id	https://openalex.org/A5009791655
authorships[5].author.orcid
authorships[5].author.display_name	Carole Gourmelon
authorships[5].countries	FR
authorships[5].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[5].affiliations[0].raw_affiliation_string	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[5].institutions[0].id	https://openalex.org/I4210147289
authorships[5].institutions[0].ror	https://ror.org/05jm9mh74
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I4210147289
authorships[5].institutions[0].country_code	FR
authorships[5].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[5].author_position	middle
authorships[5].raw_author_name	C. Gourmelon
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[6].author.id	https://openalex.org/A5113911483
authorships[6].author.orcid
authorships[6].author.display_name	M. Robert
authorships[6].countries	FR
authorships[6].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[6].affiliations[0].raw_affiliation_string	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[6].institutions[0].id	https://openalex.org/I4210147289
authorships[6].institutions[0].ror	https://ror.org/05jm9mh74
authorships[6].institutions[0].type	healthcare
authorships[6].institutions[0].lineage	https://openalex.org/I4210147289
authorships[6].institutions[0].country_code	FR
authorships[6].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[6].author_position	middle
authorships[6].raw_author_name	M. Robert
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[7].author.id	https://openalex.org/A5026072875
authorships[7].author.orcid
authorships[7].author.display_name	L.E. Dumas
authorships[7].countries	FR
authorships[7].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[7].affiliations[0].raw_affiliation_string	Pharmacy, Centre Rene Gauducheau, Nantes, France
authorships[7].institutions[0].id	https://openalex.org/I4210147289
authorships[7].institutions[0].ror	https://ror.org/05jm9mh74
authorships[7].institutions[0].type	healthcare
authorships[7].institutions[0].lineage	https://openalex.org/I4210147289
authorships[7].institutions[0].country_code	FR
authorships[7].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[7].author_position	middle
authorships[7].raw_author_name	L. Dumas
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Pharmacy, Centre Rene Gauducheau, Nantes, France
authorships[8].author.id	https://openalex.org/A5074282080
authorships[8].author.orcid
authorships[8].author.display_name	C. Folliard
authorships[8].affiliations[0].raw_affiliation_string	Pharmacy, Centre Paul Papin, Angers, France
authorships[8].author_position	middle
authorships[8].raw_author_name	C. Folliard
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Pharmacy, Centre Paul Papin, Angers, France
authorships[9].author.id	https://openalex.org/A5071553983
authorships[9].author.orcid	https://orcid.org/0000-0002-5196-5908
authorships[9].author.display_name	Mario Campone
authorships[9].countries	FR
authorships[9].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[9].affiliations[0].raw_affiliation_string	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[9].institutions[0].id	https://openalex.org/I4210147289
authorships[9].institutions[0].ror	https://ror.org/05jm9mh74
authorships[9].institutions[0].type	healthcare
authorships[9].institutions[0].lineage	https://openalex.org/I4210147289
authorships[9].institutions[0].country_code	FR
authorships[9].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[9].author_position	middle
authorships[9].raw_author_name	M. Campone
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[10].author.id	https://openalex.org/A5039803490
authorships[10].author.orcid	https://orcid.org/0000-0002-5273-0561
authorships[10].author.display_name	Jean‐Sébastien Frenel
authorships[10].countries	FR
authorships[10].affiliations[0].institution_ids	https://openalex.org/I4210147289
authorships[10].affiliations[0].raw_affiliation_string	Medical Oncology, Centre Rene Gauducheau, Nantes, France
authorships[10].institutions[0].id	https://openalex.org/I4210147289
authorships[10].institutions[0].ror	https://ror.org/05jm9mh74
authorships[10].institutions[0].type	healthcare
authorships[10].institutions[0].lineage	https://openalex.org/I4210147289
authorships[10].institutions[0].country_code	FR
authorships[10].institutions[0].display_name	Centre Hospitalier René-Dubos
authorships[10].author_position	last
authorships[10].raw_author_name	J-S. Frenel
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	Medical Oncology, Centre Rene Gauducheau, Nantes, France
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.019/19938751/mdx365.019.pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Efficacy of palbociclib plus fulvestrant in advanced Hormone Receptor-positive (HR+) metastatic breast cancer (MBC) pretreated with everolimus: Real-life data from the french temporary authorization for use (TAU) at the Institut de Cancérologie de l’Ouest
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12829
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9995999932289124
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Advanced Breast Cancer Therapies
related_works	https://openalex.org/W4206711305, https://openalex.org/W4232409591, https://openalex.org/W2982700532, https://openalex.org/W2892043300, https://openalex.org/W2897446380, https://openalex.org/W3216407617, https://openalex.org/W3161515104, https://openalex.org/W4283528480, https://openalex.org/W2588818478, https://openalex.org/W3203106735
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1093/annonc/mdx365.019
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S41454044
best_oa_location.source.issn	0923-7534, 1569-8041
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0923-7534
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of Oncology
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.license	publisher-specific-oa
best_oa_location.pdf_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.019/19938751/mdx365.019.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/publisher-specific-oa
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of Oncology
best_oa_location.landing_page_url	https://doi.org/10.1093/annonc/mdx365.019
primary_location.id	doi:10.1093/annonc/mdx365.019
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S41454044
primary_location.source.issn	0923-7534, 1569-8041
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0923-7534
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of Oncology
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.license	publisher-specific-oa
primary_location.pdf_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.019/19938751/mdx365.019.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/publisher-specific-oa
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of Oncology
primary_location.landing_page_url	https://doi.org/10.1093/annonc/mdx365.019
publication_date	2017-09-01
publication_year	2017
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	1
institutions_distinct_count	11
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5699999928474426
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.21901676
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False